Anneke M. T. van Lynden‐van Nes

Dupilumab Drug Survival and Associated Predictors in Patients With Moderate to Severe Atopic Dermatitis

Lotte S. Spekhorst, Marlies de Graaf, Nicolaas P. A. Zuithoff et al. · JAMA Dermatology · 2022 · 44 citations · Full text

Medicine, Dermatology, Pharmacotherapy +15

Successful tapering of dupilumab in patients with atopic dermatitis with low disease activity: a large pragmatic daily practice study from the BioDay registry

Lotte S. Spekhorst, Celeste M. Boesjes, Laura Loman et al. · British Journal of Dermatology · 2023 · 43 citations · Full text

Pharmacy, Dermatology, Pharmacotherapy +14

Real-world Experience of Abrocitinib Treatment in Patients with Atopic Dermatitis and Hand Eczema: Up to 28-week Results from the BioDay Registry

Esmé Kamphuis, Celeste M. Boesjes, Laura Loman et al. · Acta Dermato Venereologica · 2024 · 42 citations · Full text

Medicine, Dermatology, Pharmacotherapy +15

Long-Term Effectiveness and Reasons for Discontinuation of Dupilumab in Patients With Atopic Dermatitis

Celeste M. Boesjes, Esmé Kamphuis, Marlies de Graaf et al. · JAMA Dermatology · 2024 · 33 citations · Full text

Life Sciences, Dermatology, Immunology +9

Infection risk in atopic dermatitis patients treated with biologics and <scp>JAK</scp> inhibitors: <scp>BioDay</scp> results

Lian F. van der Gang, Keneshka Atash, Nicolaas P. A. Zuithoff et al. · Journal of the European Academy of Dermatology and Venereology · 2025 · 27 citations · Full text

Medicine, Dermatology, Pharmacotherapy +17